Ken Griffin's position in Biogen is currently worth $20.4 Million. That's 0.02% of their equity portfolio (826th largest holding). The first Biogen trade was made in Q2 2013. Since then Ken Griffin bought shares 56 more times and sold shares on 55 occasions. The investor's estimated purchase price is $44.8 Million, resulting in a loss of 55%.